Results 101 to 110 of about 19,039 (151)

Routine transfusion of Rh(D)‐positive RBCs to Rh(D)‐negative patients designated as do not resuscitate conserves Rh(D)‐negative red blood cell inventory

open access: yesTransfusion, Volume 66, Issue 6, Page 1108-1112, June 2026.
Abstract Background A minority of blood donors are Rh(D)‐negative, and Rh(D)‐negative red blood cell (RBC) products are often overutilized. As such, Rh(D)‐negative RBCs may be difficult to maintain in blood bank inventory. Study Design and Methods We changed our blood bank laboratory policy to approve non‐alloimmunized Rh(D)‐negative patients to ...
Julie Katz Karp   +5 more
wiley   +1 more source

The status of cell and gene therapy education in medical schools—An international survey

open access: yesTransfusion, Volume 66, Issue 6, Page 1160-1166, June 2026.
Abstract Introduction Cell and gene therapy (CGT) has emerged as a distinct medical field with more than 50 “Food and Drug Administration (FDA)”‐approved products treating conditions from leukemia to sickle cell disease. Despite this therapeutic revolution and the field's inherent complexity, the status of CGT education in medical schools remains ...
Edina A. Wappler‐Guzzetta   +2 more
wiley   +1 more source

Hold on to your units: Quality of red cell concentrates is only affected after multiple transient warming events

open access: yesTransfusion, Volume 66, Issue 6, Page 1180-1191, June 2026.
Abstract Background Cryopreserved red cell concentrates (RCCs) glycerolized using a high glycerol (40%) method can be stored below −65°C for up to 30 years; however, units may be inadvertently warmed above −65°C due to freezer failures, human errors, or routine inventory management.
Jayme Kurach   +8 more
wiley   +1 more source

Addressing racial disparities in representation across blood, stem cell and organ and tissue donor pools

open access: yesVox Sanguinis, Volume 121, Issue 6, Page 710-721, June 2026.
Abstract Background and Objectives Adequate representation of donors from diverse ancestral populations in blood, stem cell and organ transplantation is critical to ensuring equitable access to these lifesaving therapies. Because of population‐level differences in genetic markers, patients from racialized groups may have unique transfusion and ...
Bonnie Lu   +9 more
wiley   +1 more source

Hypoxic‐hypocapnic red blood cells in PAGGSM additive solution before and after gamma irradiation show improved metabolism

open access: yesVox Sanguinis, Volume 121, Issue 6, Page 801-808, June 2026.
Abstract Background and Objectives Hypoxic/hypocapnic (HH) treatment and storage conditions have been shown to reduce oxidative stress and improve red blood cell (RBC) quality. This study aimed to validate a good manufacturing practice HH RBC product for obtaining the licence for routine use in patients, by comparison with normoxic RBCs both without ...
Soroth Chey   +3 more
wiley   +1 more source

Long‐term forecasting of blood donations using time series of donation activity: Findings from seven blood establishments

open access: yesVox Sanguinis, Volume 121, Issue 6, Page 742-752, June 2026.
Abstract Background and Objectives To meet the long‐term demand for blood products while preserving donor health in the long run, blood establishments must recruit a sufficient number of new donors annually. To determine what will suffice, it is essential to be able to forecast future blood donation volumes as a function of new donors using estimates ...
Timo Asikainen   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy